Polymorphism in exon 6 of the dopamine D2 receptor gene (DRD2) is associated with elevated blood pressure and personality disorders in men

被引:32
作者
Rosmond, R [1 ]
Rankinen, T [1 ]
Chagnon, M [1 ]
Pérusse, L [1 ]
Chagnon, YC [1 ]
Bouchard, C [1 ]
Björntorp, P [1 ]
机构
[1] Sahlgrens Univ Hosp, Dept Heart & Lung Dis, S-41345 Gothenburg, Sweden
基金
英国医学研究理事会;
关键词
dopamine; DRD2; polymorphism; blood pressure; personality disorders; abdominal obesity;
D O I
10.1038/sj.jhh.1001231
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
A deficient dopamine D-2 receptor (DA2) formation or action may contribute to hypertension via an increase of catecholamine release. In addition, Axis II personality disorders that appears odd or eccentric (cluster A) is associated with a low density of DA2. This study sought to examine if a Ncol restriction fragment length polymorphism (C to T transition) in exon 6 of the dopamine D-2 receptor gene (DRD2) was associated with these characteristics. The genotypes (CC, CT and TT) were compared in anthropometric, endocrine, metabolic and haemodynamic variables as well as estimates of personality disorders in 284 randomly selected 51-year-old men. Homozygotes for the C allele constituted 49% of the men and homozygotes for the T allele 9%, while heterozygotes were 41%. The TT genotype was associated with elevated systolic and diastolic blood pressure, independent of obesity and endocrine abnormalities, including the hypothalamic-pituitary-adrenal axis regulation. Moreover, the TT genotype was significantly more frequent among subjects with grade 1 (mild) hypertension (> 140/90 mm Hg) compared to normotensive subjects (< 130/85 mm Hg). The polymorphism in exon 6 of the DRD2 was also significantly associated with cluster A personality disorders. These results suggest that a polymorphism in exon 6 of the DRD2 examined with the restriction enzyme Ncol is associated with an elevated blood pressure, independent of obesity. Paranoid or schizoid personality disorders is also associated with a polymorphism of the DRD2, which might be associated with a previously demonstrated low density of this receptor.
引用
收藏
页码:553 / 558
页数:6
相关论文
共 38 条
[11]  
Kestler LP, 2000, NEUROPSY NEUROPSY BE, V13, P48
[12]   THE HETEROGENEITY OF DOPAMINE INVOLVEMENT IN ESSENTIAL-HYPERTENSION [J].
KUCHEL, O .
CLINICAL AND EXPERIMENTAL HYPERTENSION PART A-THEORY AND PRACTICE, 1989, 11 :217-225
[13]  
LANGSTON JW, 1992, SCI BASIS TREATMENT, P33
[14]   EFFECT OF THE DOPAMINE-D2 RECEPTOR AGONIST QUINPIROLE ON THE INVIVO RELEASE OF DOPAMINE IN THE CAUDATE-NUCLEUS OF HYPERTENSIVE RATS [J].
LINTHORST, ACE ;
DELANG, H ;
DEJONG, W ;
VERSTEEG, DHG .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 201 (2-3) :125-133
[15]   ENDOGENOUS DOPAMINE (DA) AND DA2 RECEPTORS - A MECHANISM LIMITING EXCESSIVE SYMPATHETIC-ADRENAL DISCHARGE IN HUMANS [J].
MANNELLI, M ;
PUPILLI, C ;
FABBRI, G ;
MUSANTE, R ;
DEFEO, ML ;
FRANCHI, F ;
GIUSTI, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 66 (03) :626-631
[16]   EFFECTS OF DIFFERENT DOPAMINERGIC ANTAGONISTS ON BROMOCRIPTINE-INDUCED INHIBITION OF NOREPINEPHRINE RELEASE [J].
MANNELLI, M ;
DELITALA, G ;
DEFEO, ML ;
MAGGI, M ;
CUOMO, S ;
PIAZZINI, M ;
GUAZZELLI, R ;
SERIO, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1984, 59 (01) :74-78
[17]  
Meador-Woodruff J H, 1994, Ann Clin Psychiatry, V6, P79, DOI 10.3109/10401239409148986
[18]   Dopamine receptors: From structure to function [J].
Missale, C ;
Nash, SR ;
Robinson, SW ;
Jaber, M ;
Caron, MG .
PHYSIOLOGICAL REVIEWS, 1998, 78 (01) :189-225
[19]   IDENTIFICATION AND CHARACTERIZATION OF POSTSYNAPTIC D1-DOPAMINE AND D2-DOPAMINE RECEPTORS IN THE CARDIOVASCULAR-SYSTEM [J].
MISSALE, C ;
CASTELLETTI, L ;
MEMO, M ;
CARRUBA, MO ;
SPANO, PF .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1988, 11 (06) :643-650
[20]   Diagnostic and Statistical Manual of Mental Disorders [J].
Mittal, Vijay A. ;
Walker, Elaine F. .
PSYCHIATRY RESEARCH, 2011, 189 (01) :158-159